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Objectives: Since 2010, several researches demonstrated that microbiota dynamics
correlate and can even predispose to Hirschsprung (HSCR) associated enterocolitis
(HAEC). This study aims at assessing the structure of the microbiota of HSCR patients
in relation to extent of aganglionosis and HAEC status.
Methods: All consecutive HSCR patients admitted to Gaslini Institute (Genova, Italy)
between May 2012 and November 2014 were enrolled. Institutional review board (IRB)
approval was obtained. Stools were sampled and 16S rDNA V3-V4 regions were
sequenced using the Illumina-MiSeq. Taxonomy assignments were performed using
QIIME RDP. Alpha diversity indexes were analyzed by Shannon and Simpson Indexes,
and Phylogenetic Diversity.
Results: We enrolled 20 patients. Male to female ratio was 4:1. Six patients suffered
from Total Colonic Aganglionosis (TCSA). Considering sample site (i.e., extent of
aganglionosis), we confirmed the known relationship between sample site and both
biodiversity and composition of intestinal microbiota. Patients with TCSA showed lower
biodiversity and increased Proteobacteria/Bacteroidetes relative abundance ratio. When
addressing biodiversity, composition and dynamics of TCSA patients we could not find
any significant relationship with regard to HAEC occurrences.
Conclusions: The composition of HAEC predisposing microbiota is specific to each
patient. We could confirm that total colon resections can change the composition of
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intestinal microbiota and to dramatically reduce microbial diversity. The subsequent
reduction of system robustness could expose TCSA patients to environmental microbes
that might not be part of the normal microbiota. Future long-term studies should
investigate both patients and their family environment, as well as their disease history.
Keywords: metagenomics, enterocolitis, Hirschsprung, RET gene, aganglionosis
INTRODUCTION
Enterocolitis (HAEC) is an extremely serious, life-threatening
complication that can occur in children with Hirschsprung
disease (HSCR) pre- and even post-operatively. Despite a number
of studies, the causative agents of HAEC are still elusive. Standard
culturomics technologies did not lead to the discovery of
microbial pathogens causing HAEC. Novel culture independent
approaches based on DNA sequencing of target genes or of
the whole bacterial DNA content hold the promise to discover
the causative agents and the etiology of HAEC. Since 2006 (1)
metagenomics in children has been used to address the role of
intestinal microbiota in the etiology of a number of diseases
(1–11). Only a minority of papers addressed HSCR and HAEC
(6, 12–14). In 2010, our group carried out a pilot genomic
study in a single patient with HSCR and demonstrated that
HAEC can correlate to changes in gut bacterial dynamics (12).
Ward and co-workers later on reported a sustained abnormal
microbiota in an animal model of HSCR (13). Yan in 2014
(6) and Frykman in 2015 (14) investigated HSCR patients with
or without HAEC. Both authors did not find any significant
difference apart from the latter who reported an altered Candida
community in those with HAEC (14). Of note, Li et al. in
2016 reported a significantly different microbiome in HSCR
patients with HAEC (15). Proteobacteria were significantly more
represented in patients with HAEC whereas Bacteroidetes were
significantly more represented in patients without. Also HSCR
patients had a relatively distinct, more stable community than
the HAEC and HAEC-R patients (previously settled HAEC
episode), suggesting that enterocolitis may either be caused by or
result in a disruption of the patient’s uniquely adapted intestinal
flora. The intestinal microbiota associated with enterocolitis may
persist following symptom resolution and can be implicated in
symptom recurrence. In another recent study on a mouse model
of HSCR, the metagenomics analysis of Ednrb−/− and wild
type mice showed that mutants had a distinct microbiota with
respect to wild type (WT) and that the HAEC group had lower
alpha diversity by Chao1 index compared with WT. Also the
animals with HAEC had increased proportion of Akkermansia
genus and reduced Bacteroidetes phylum compared with the
NO HAEC and WT groups, suggesting Akkermansia may
contribute to development of enterocolitis while Bacteroidetes
may be protective (16). Finally, another study on Finnish patients
showed how those with HD and HAEC had a significantly
altered intestinal microbiome compared to healthy individuals,
characterized by a lack of richness and pathologic expansions
of taxa, particularly Enterobacteria and Bacilli (17). These
initial studies did not lead to a predictive profile for HAEC
(18, 19). Nonetheless, no mention was done either regarding
extent of aganglionosis or diversity measures (15). Here we
report results of a metagenomics study on fecal microbiota
performed on HSCR patients, addressing limitations, drawbacks
and potential benefits of such approach, delineating future
perspectives in this field of research.
METHODS
Patients
All pediatric patients with HSCR consecutively admitted to
Giannina Gaslini Institute (Genova, Italy) between May 2012
and November 2014 were eligible for this study. Institutional
Ethical committee approval was obtained by the Review Board
of Giannina Gaslini Institute on November 2009 as part of a
wider research project on HSCR. A specific informed consent
was signed by all participant families. Inclusion criteria were:
(1) diagnosis of HSCR based on histochemical assessment of
adequate rectal suction biopsies, as previously reported (20);
(2) exhaustive data regarding extent of aganglionosis (adequate
intraoperative histology) and regarding personal history with
specific regard to previous bouts of HAEC; (3) stool sampling
available both from preoperative and postoperative periods.
Exclusion criteria were (1) refusal of signing the informed
consent; (2) failure to pass internal quality control; (3) inadequate
sampling or storage.
Definitions
HSCR, Hirschsprung’s disease; RSA, HSCR with aganglionosis
extended up to the colonic splenic flexure (i.e., Rectosigmoid
Aganglionosis); L-HSCR, Long HSCR with aganglionosis
extended beyond the splenic flexure up to ascending colon;
TCSA, HSCR with aganglionosis extended to the whole colon
(i.e., Total Colonic Aganglionosis); HAEC, Enterocolitis
diagnosed according to the combination of Pastor criteria (21)
(to confirm the diagnosis) and Elhalaby criteria (22) (to grade
HAEC severity).
Stools Collection, Storage, and Delivery
Spontaneous stools were collected and stored frozen (−20◦C
up to 48 h and −80◦C afterwards) until shipment to the
reference center for processing of fecal samples (Bethesda,
Maryland, USA). Stools from Total Colonic Aganglionosis
(TCSA) patients belonged to stoma bags preoperatively and from
direct bowel movements postoperatively (in both cases from the
ileum) whereas stools from Rectosigmoid Aganglionosis (RSA)
or long (L)-HSCR belonged from bowel nursing (enema or
rectal tube) preoperatively and from direct bowel movements
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postoperatively. Time-points for stool sampling were: (1)
before surgery (Timepoint 1, preoperative hospital stay), (2)
intraoperative (timepoint 2), and (3) postoperatively 7 to 10
after pull-through (timepoint 3). Only timepoints 1 and 3
(preoperative and postoperative, respectively) were assessed in
this study.
Clinical Features and Molecular Genetics
All patients included in this study underwent a thorough
phenotype assessment as previously published (23).
Demographic data, phenotype results, HAEC status, surgical
details, possible complications and long-term outcome were
recorded and stored in a digital database according to data
protection Act. Furthermore, all patients underwent sequencing
of the RET gene coding portion (21 exons flanked by at least
20 bp of intronic sequences) as part of the multidisciplinary
diagnostic algorithm, as previously published (24). In order
to identify mutations that are potentially involved in HSCR,
the results of molecular genetics, consisting of (1) putatively
pathogenic RET mutations; (2) common variants among which
those known to represent HSCR risk modulating factors (25),
were recorded in the same database as above.
16S rDNA Sequencing and Processing
Amplification and sequencing of the 16S rDNA hypervariable
V4 region was performed as previously described using the
Illumina MiSeq platform with 150 bp paired end reads and V2
chemistry (26). Sequences were demultiplexed with FLEXBAR
(27) and assembled using PEAR (28). Sequences were then
quality filtered and restricted to length of 245–255 nt, which
retained 9.77 million reads of the filtered 9.78 million reads.
The sequences were then analyzed using scripts within the
QIIME package (29). Sequences were first clustered into de novo
operational taxonomic units (OTUs) defined by 97% sequence
identity using UCLUST (30). A representative set of sequences
for the OTUs was selected using the QIIME “most abundant”
selection method. Taxonomy assignments for the representative
sequences were performed using the QIIME RDP wrapper with
an 80% cut-off for bootstrap confidence in assignment (31).
Unclassified sequences and reads classified as Cyanobacteria were
removed. The representative sequences were then aligned using
PyNAST with a minimum length of alignment cutoff of 150
nucleotides and a minimum percent identity cutoff value of
75% (32). Alignments were performed against the Greengenes
13_8 taxonomy core-set alignment sequences (33). Chimeras
were removed from the aligned reads using ChimeraSlayer (34).
ChimeraSlayer identified 21,593 OTUs (4.0%) out of 537,481
total OTUs as chimeric. OTUs that possessed <2 sequences
and did not occur in more than one sample were removed.
Taxonomy summaries were further filtered to only include OTUs
that make up at least 0.5% of the total sequences. Rarefaction
of the samples was performed on all samples at a depth of 7070
sequences to ensure homogeneity in sample size for downstream
analysis. Phylogenetic tree construction of the aligned sequences
was performed using FastTree (35). The phylogenetic tree was
used for calculation of UniFrac (weighted and unweighted) beta
diversity distance matrices (36).
Statistical Analyses
The results were compared according to length of aganglionosis,
timepoints, andHAEC status (HAEC episodes either experienced
during the study period or before enrollment but reported
in personal history (pre-HEAC). The single patient with L-
HSCR could not be categorized as classic or ultralong HSCR
and was excluded from this statistical analysis in order to
avoid misinterpretation (Table 1). Diversity indexes as well
as phylogenetic analysis were compared in patients with
RSA and TCSA regardless of timepoints. TCSA patients that
represented the core of our study underwent a further analysis
based on HAEC status and timepoints of stool sampling.
The R ggplot2 package was used for plotting (37). Alpha
diversity index analyses of the samples were conducted using
QIIME and the constructed phylogenetic tree to calculate the
Shannon index (38), Simpson Index (39), and Phylogenetic
Diversity (PD) (40). Pairwise comparison with Wilcoxon rank
sum test was used to address Alpha diversity measures.
Differences in categorical variables were addressed with chi-
square or Fisher exact test, when appropriate. All tests
were 2-tailed. A p-value lower than 0.05 was considered as
statistically significant.
RESULTS
Overall Samples Distribution
During the study period, we admitted 41 consecutive HSCR
patients. Due to the technical difficulties in frozen storage, only
31 of these patients provided adequate material to be sent to
Bethesda (NIH, USA) for metagenomics. Of these 31 patients,
only 20 provided both preoperative and postoperative specimen
that passed internal quality controls. To summarize, out of 41
eligible HSCR patients, preoperative and postoperative stool
samples were collected from 20 HSCR patients, 13 suffering
from Rectosigmoid Aganglionosis (RSA), 1 L-HSCR and 6 Total
Colonic Aganglionosis (TCSA). Median age at enrollment of
these 20 patients was 16 months (ranging between 2 months
and 13 years). A total of 40 stool samples (20 preoperative
and 20 postoperative) were sequenced for 16S rDNA. In order
to increase results reliability and to address HSCR forms with
the highest risk of HAEC occurrences, we mostly focused
on patients with TCSA that represented the core of our
study (Table 1).
Demographics of TCSA Patients
Six patients with TCSA were included. Male to female ratio
was 2:1. Median age at enrollment was 15.5 months (range 9
to 26 months). RET mutations were detected in 7 out of 20
patients (35%), 4 of whom suffering from TCSA (67%). Three
of these 4 nucleotide changes lead to truncating mutations
and, interestingly, none was associated with HSCR cases
complicated by HAEC manifestations. Two patients reported
a previous history of HAEC (subject A and K), one (subject
C) developed HAEC postoperatively well after postoperative
timepoint (Table 1). RET mutations did not correlate either
with protection or predisposition to HAEC (p = 0.4000).
Four associated anomalies were detected in 3 patients. These
included Congenital Anomalies of the Kidney and Urinary Tract
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TABLE 1 | Patients with TCSA in our series.
N. of pts M:F ratio RET mutations (%) Associated
anomalies
HAEC
RSA 13 5.5:1 3 (23%) 4 (31%) 1 (8%)
L-HSCR* 1 n.a. 0 (n.a.) 0 (n.a.) 1 (n.a.)
TCSA 6 2:1 4 (67%) 3 (50%) 3 (50%)
DETAILS ON PATIENTS WITH TCSA (TIME POINTS COMPARED FOR DYNAMIC CHANGES)
ID of TCSA Gender Age Detailed RET mutation Associated
anomalies
HAEC
A M 15 months None CAKUT Post severe
C M 16 months None None Pre severe
K M 9 months c.833C>A (p.T278N) CAKUT Post severe
L M 20 months c.820_820delG
(p.A274Rfs*38)
c.2075_2076delinsAA (p.A692E)
None None
N F 26 months c.2772_2773insT (D925*) GUT + EYE None
Q F 14 months c.2829_2830insGGAG
(p.I944Gfs*16)
None None
The prevalence of associated anomalies is in line to what previously published by our group (20). The table summarizes data regarding RET mutations, Associated Anomalies and HAEC
status of the whole series of patients who underwent metagenomics, focusing on patients with TCSA who underwent a deeper assessment. None of the patients received antibiotics
close to preoperative timepoint sampling. All TCSA patients received antibiotic prophylaxis for the first 3 days postoperatively (4 to 7 days before postoperative timepoint sampling).
N, number; pts, Patients; n.a, not assessed; HAEC, Hirschsprung’s associated enterocolitis; RSA, RectoSigmoid Aganglionosis; L-HSCR, Long Hirschsprung form; TCSA, Total Colonic
Aganglionosis; RET, Rearranged During Transfection proto-oncogene. Post Severe, Severe HAEC following definitive surgery; Pre Severe, Severe HAEC before diagnosis; CAKUT,
Congenital Anomaly of the Kidney and Urinary Tract; GUT, Congenital Intestinal Malformation; EYE, Eye abnormality. *The asterisks in the new nomenclature recommendations indicate
the stop codon. In particular it refers to the protein and the stop signal (https://varnomen.hgvs.org/).
(CAKUT) (n= 2), Gastrointestinal anomalies (n= 1), and Visual
Impairment (n= 1) (Table 1).
Microbiota Diversity and Composition
Comparing TCSA to RSA (20 Patients, 40
Samples)
Diversity
The diversity measures (Figure 1) were calculated based on the
results derived by the overall assessment of specimen provided
by each group (13 RSA and 6 TCSA, both timepoints). The
diversity of gut microbial communities was assessed with alpha
diversity measures. We calculated the number of observed
species-level OTUs in each sample and found that the gut of
RSA patients contained a higher number of species-level OTUs
than the gut microbiota of TCSA patients (mean difference
= 278 species; p <0.001). Similarly, the Shannon index (35),
which measures the richness and evenness of a community, was
higher in RSA patients than TCSA patients (mean difference =
1.51; p < 0.01). Phylogenetic Diversity (PD) (39), which takes
into account phylogeny, further confirmed our findings that
RSA patients possessed greater microbial diversity compared to
TCSA ones (mean difference = 13.42; p < 0.005). However,
the Simpson Index (38) did not significantly differ between
RSA and TCSA patients. The Simpson index measures diversity
by calculating the evenness of OTUs in each community and
penalizes communities dominated by a small number of OTUs
(Figure 1).
Composition
We assessed microbial composition by comparing the relative
abundances of taxa at the phylum and genus level. At the
phylum level differences between RSA and TCSA microbiota
were even more striking, specifically with regard to the presence
of Bacteroidetes (Figure 2). Nearly 70% of RSA patients (69%)
had communities composed of over 33% Bacteroidetes whereas
all TCSA communities contained <2% Bacteroidetes, which
was found to be a significant difference (mean difference =
40.83%; p < 0.05). A greater presence of Proteobacteria in TCSA
microbiota compared to RSA microbiota was also observed
(mean difference = 32.27%; p <0.05). The remaining two
classifiable phyla found in all of the samples, Firmicutes and
Actinobacteria, did not significantly differ in relative abundance
between the two groups.
When considering the communities at the genus level, we
observed a prominent composition (>25%) of Bacteroides in
the majority of the RSA patients’ gut microbiota, whereas all
of the TCSA patients contained <1% of Bacteroides in their
gut microbiota. Similarly, we observed a significant increase
of Alistipes (a genus in the same Phylum as Bacteroides,
Bacteroidetes) in the gut microbiota of RSA patients when
compared to the TCSA patients (mean difference = 1.76%;
p < 0.05). Conversely, we found that members of the genus
Enterococcus (a member of the Firmicutes Phylum) were more
prevalent in the microbiota of TCSA patients (mean difference=
2.44%; p < 0.05).
TCSA Patients (6 Patients, 12 Samples)
Gut microbiota of 6 HSCR patients with TCSA was assessed
before and after surgery (comparing timepoints) performed
to restore bowel continuity and reverse the stoma (Figure 3).
All preoperative sampling were obtained by the stoma.
Three patients (Subjects L, N, and Q) never experienced
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FIGURE 1 | The diversity of gut microbial communities was assessed through four alpha diversity measures. Together, these results suggest that ileal stools belonging
to TCSA carry lower microbiota diversity.
FIGURE 2 | We assessed microbial composition by comparing the relative
abundances of taxa at phylum level. When considering the communities at the
phylum level, differences between RSA and TCSA microbiota were clearly
evident. Bacteroidetes represented over 33% of all bacteria in RSA and where
basically absent (<2%) in TCSA. Similarly, Proteobacteria accounted for nearly
40% of all bacteria in TCSA and for <5% in RSA. Conversely, Firmicutes and
Actinobacteria were present both in RSA and TCSA without statistically
significant differences.
episodes of HAEC. One patient (Subject C) experienced
an HAEC episode preoperatively, while the two remaining
patients experienced post-operative HAEC episodes (Subjects A
and K).
We analyzed changes in alpha diversity between the two
timepoints using three metrics: OTU richness (the number of
observed OTUs in a sample), Shannon Diversity (a measure of
OTU richness and evenness), and PD whole tree (a metric that
takes phylogeny into account). Four of six subjects increased in
Shannon diversity post-operatively. The two subjects that did not
increase in Shannon diversity (Subjects A and L) were stable by
this metric as well as number of OTUs and PDwhole tree. For PD
whole tree and OTU richness, most patients also trended toward
an increase, though two subjects remained stable or slightly
decreased by these metrics (Subject C and Subject N).
Though our sample size was not large enough to adequately
power statistical comparisons, we noted that composition of
the gut microbiota was highly variable, both pre- and post-
operatively, regarding genus level taxonomy. Pre-operatively
Subject A was predominantly colonized withVeillonella, Subjects
K and Q were predominantly colonized by Enterobacteriaceae
family, Subject C was predominantly colonized with Clostridium,
and Subject N was predominantly colonized with Lactobacillus
genus. Subject L was not dominantly colonized by a single
genus level taxa and contained a more diverse mixture. For all
subjects, there was a drastic shift in composition post-operatively,
though we did not detect any specific trend in this regard. At
a phylum level, Proteobacteria showed a striking predominance
over other phyla either preoperatively or postoperatively but
without relationship with HAEC occurrences or HAEC status.
In fact, HEAC status, as well as genetic background and
phenotype did not show clear correlations with gut microbiota
both pre- and post-operatively (Spearman correlation, p = 0.40;
see Table 1, Figure 3).
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FIGURE 3 | Diversity and composition in TCSA before and after surgery. X-axis depicts timepoints of sample collection: pre-operative (“1”) and post-operative (“3”).
Subjects A, K, and C either developed HAEC postoperatively (pre-HAEC—HAEC status at stool sampling) or preoperatively (HAEC—HAEC status at stool sampling).
Subjects L, N, and Q never developed. The top graph of each panel represents alpha diversity, normalized to values of sample collected pre-operatively, with each
color line representing a different metric. The dotted line on each graph is set to 1.0. The bottom panel illustrates relative abundance of taxa at genus level.
DISCUSSION
Our study was aimed at addressing the effect of ultralong
aganglionosis (TCSA) and its multiple implications, namely
genetic background (higher prevalence of RET mutations),
motility issues (higher prevalence of obstructive symptoms), and
HAEC occurrences [higher frequency of HAEC episodes (12, 21,
22)] on gut microbiota composition. In fact, though it is still
unknown if those variables are independent one from the others,
RSA and TCSA must be considered separately when addressing
HSCR patients.
Only a few published papers compared ileal and colonic
fecal microbiota in children with HSCR-associated enterocolitis
(HAEC). Available studies mostly refer to newborns or ex-
preterm with a history of necrotizing enterocolitis or to children
with inflammatory bowel diseases (41–45). The only study
comparing microbiota of ileal and colonic stools in healthy
subjects, is that by Zoetendal et al. in 2012 (46) but the authors
included only adult subjects. Even so, our study confirmed
that ileal samples have a lower microbiota diversity when
compared to colonic ones, regardless of the presence of a stoma
or not, in accordance to work reported by Zoetendal et al.
(46). Recently, Barret et al. compared two preterm babies with
different stomas (ileal and colonic) and followed them up to
7 months of age (41). They reported that Bifidobacteria and
Enterobacteriaceae dominate at a genus level in the ileal stools
samples (41). Our results are consistent with these findings
with similar preponderances at a genus level. Of note, statistical
analysis failed to show significant differences in terms of diversity
and composition with relation to HAEC occurrences in TCSA
patients, thus confirming the heterogeneity of gut microbiota
and the difficulty in finding a clear and univocal marker for
HAEC predisposition.
Nonetheless, the lower diversity and variable composition
of microbiota throughout time points confirms that either
with a stoma or not, patients with TCSA have different gut
microbiota compared to those with RSA. This aspect could be
easily expected basing on previous reports concerningmicrobiota
diversity and composition in different bowel sites (41–46).
Even so, as TCSA patients are well known to be susceptible
to HAEC (12, 21, 22, 47), we speculate that either reduced
diversity in TCSA patients can be merely related to a different
sampling site or that this aspect has a pathogenetic role in
terms of HAEC predisposition/facilitation. Alternatively, the
well-known dysmotility and fecal stasis observed in TCSA
patients could lead to bacterial overgrowth that can interfere
with homeostasis and bacterial dynamics even more. In case of
bacterial overgrowth, a potentially harmful microbial species can
outcompete commensals very rapidly and lead to HAEC as a
result of systemic reaction to this dysbiosis. This argument is
supported by the factthat we could not observe a specific genus
or phylum significantly associated with HAEC occurrence within
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TCSA patients. Nonetheless, our series of patients with TCSA
proved to have a significantly higher abundance of Proteobacteria
when compared to RSA ones. In particular, 5 out of 12 samples
belonging to TCSA patients were more than 80% composed by
Proteobacteria. Conversely, Bacteroidetes were basically absent.
The total loss of the colon undermines the existence of a specific
organ, composed both of mammalian cells and microbial cells.
The colon microbiota provides the system with a fundamental
stabilizing function, of crucial importance for the robustness of
the whole microbial and immune system. The colonic diversity
and richness creates a resilient, reliable, and robust microbial
community that can easily cope with potential insults, including
the colonization from environmental and food microbiota. In
this context, the absence of Bacteroidetes affects the production
of short chain fatty acids (SCFAs) which are fundamental for
intestinal homeostasis. Our result is thus in agreement with
a recent report that showed how fecal samples from HAEC
children showed a 4-fold decline in total SCFA concentration vs.
non-HAEC HSCR patients (48). In particular, the authors found
reduced acetate and increased butyrate in HAEC children, with
10 of 12 butyrate-producing genera as well as 3 of 4 acetate-
producing genera demonstrated multi-fold expansion. Yet, we
cannot demonstrate whether Proteobacteria preponderance and
Bacteroidetes deficiency are linked to sampling site (ileal vs.
colonic) or to HAEC predisposition, as recently suggested
by Li et al. (15). Noteworthy, sampling site of their HAEC
patients belonged more frequently to ileum or right colon, thus
introducing a significant bias in the interpretation of their results
(15). In TCSA, the ecological resilience of the microbiota to
resist an insult is deeply undermined. Thus, TCSA patients have
a fragile ileal microbial community, which may be extremely
sensitive to dysbiosis that is otherwise harmless in a normal
system. This is evident not only by the recurrence of HAEC,
but also the variations of microbial compositions between
individual patients.
This result is shown not only by the recurrence of HAEC
but also from the extreme interindividual variability of the
microbial composition. In absence of the colon TCSA patients
have a highly variable microbiota, lacking fundamental species
associated to heath in normal individuals, such as Bacterioidetes.
The abundance of Proteobacteria also reflects the invasion
from environmental communities, that are free to thrive in an
environment that would be normally precluded to them by the
presence of Bacterioidetes. Thus, HAEC should be seen not as a
response to a pathogen, but as a response to a community that
normally should not be present in the ileum, or in the colon,
eliciting deleterious consequences. This explanation of our results
is further supported by the most striking finding of a recent
study on HAEC in a mouse model of HSCR that suggested how
Akkermansia, a microorganism normally seen as protective, may
contribute to development of enterocolitis while Bacteroidetes
may be protective. Less abundant genera that were reduced in
HAEC were Dysgonomonas and Clostridium XIVa, which may
play a protective role (16). Taken as a whole our findings suggest
that the use of therapies targeted at Clostridium difficile, without
sufficient confirmation for Clostridium difficile overgrowth,
might be detrimental in patients withHAEC following total colon
resection. Even so, it is still possible that certain composition of
the intestinal microbiota, as that reported by Li et al. or in our
study, can predispose to HAEC in case of a susceptible genetic
and immunologic background well known to be significantly
more frequent in TCSA (22). In agreement with previous
results (49) 65% of TCSA and 20% of RSA patients in our
study have RET mutations. As recently published by our group
(50), these mutations could determine abnormal expression of
RET-dependent and independent pro-inflammatory programs
that might predispose to HAEC occurrence. RET sequencing
in our study could not be correlated to the incidence of
HAEC mostly due to the limited number of HAEC-TCSA
in our series of patients. We speculate that the interaction
of a less diverse and compositionally peculiar gut microbiota
(preponderance of Proteobacteria over Bacteroidetes) in patients
with an imbalanced RET-dependent and independent immunity
(regardless of the loss-of-function effect of RET mutations) could
facilitate HAEC onset and/or predisposition. In this perspective,
the defects observed inHSCR are not restricted to the aganglionic
segment but extend to the mucosal immune system within
and beyond the gastrointestinal tract, including the microbiota
composition (50).
Although our study underlined the potential of metagenomics
and improves the understanding of the relationship between
microbiota, host, and immune system in patients with HSCR, it
suffered important limitations. First of all, although all patients
were sampled relatively far away from antibiotic therapy, we
cannot exclude long term effects of antibiotic treatment. The
microbiota composition proved to be patient-specific and likely
depend on patients’ personal history, as previously reported
by Barrett et al. and Zoetendal et al. (41, 46). In particular,
genera and phyla were heterogeneous in patients from our series
and there was no specific and reproducible common pattern
according to length of aganglionosis, genotype, phenotype, and
HAEC status. This was evident when we addressed stools
composition of TCSA patients with and without HAEC whose
relative abundance of bacterial taxa at each time point were
basically not comparable. In context of bacterial diversity and
community dynamics, we could observe some of the most
intriguing potentials of metagenomics in HSCR, all pointing
to a lack of robustness in the gut microbiota. We argue this
is due to the loss of the organ principally responsible for
maintaining the reservoir of those microbes providing the buffer
effect, with a loss of biodiversity corresponding to a loss of
resilience. On this specific regard, it appears extremely important
to achieve a heathy status by reconstituting this microbial buffer,
in order to re-establish a minimal resilience and homeostasis.
On the ground of these considerations, strategically designed
fecal transplant defined by composition and the abundance enjoy
exciting potential to address this issue in TCSA patients.
To conclude, our study confirmed the enormous potential
of metagenomics in HSCR but underlined the importance
of identifying the proper subset of patients for this powerful
methodology. Based on the prevalence of HAEC, patients
with TCSA represent the ideal subgroup to study HAEC
susceptibility. A longitudinal long-term study on high-risk
patients will presumably provide information that could be
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better compared, analyzed, and possibly applied or transferred to
the general HSCR population. At present, we can only speculate
that higher biodiversity could play a role in maintaining
gut homeostasis and that its disruption could facilitate
HAEC development.
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